Nancy Stuart
2018
In 2018, Nancy Stuart earned a total compensation of $1.9M as Chief Operating Officer at Concert Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,172 |
|---|---|
| Option Awards | $1,316,651 |
| Salary | $412,186 |
| Other | $11,022 |
| Total | $1,908,031 |
Stuart received $1.3M in option awards, accounting for 69% of the total pay in 2018.
Stuart also received $168.2K in non-equity incentive plan, $412.2K in salary and $11K in other compensation.
Rankings
In 2018, Nancy Stuart's compensation ranked 5,984th out of 14,244 executives tracked by ExecPay. In other words, Stuart earned more than 58.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,984 out of 14,244 | 58th |
Division Manufacturing | 2,278 out of 5,765 | 61st |
Major group Chemicals And Allied Products | 853 out of 2,128 | 60th |
Industry group Drugs | 713 out of 1,817 | 61st |
Industry Pharmaceutical Preparations | 556 out of 1,391 | 60th |
Source: SEC filing on April 29, 2019.
Stuart's colleagues
We found two more compensation records of executives who worked with Nancy Stuart at Concert Pharmaceuticals in 2018.